| Primary |
| Osteoporosis |
50.0% |
| Gastrooesophageal Reflux Disease |
25.0% |
| Postmenopause |
25.0% |
|
|
| Secondary |
| Drug Use For Unknown Indication |
35.7% |
| Hormone Replacement Therapy |
16.1% |
| Menopausal Symptoms |
7.1% |
| Endometriosis |
5.4% |
| Gastrooesophageal Reflux Disease |
5.4% |
| Product Used For Unknown Indication |
5.4% |
| Arthralgia |
3.6% |
| Breast Cancer |
3.6% |
| Chest Pain |
3.6% |
| Lymphangitis |
3.6% |
| Menopause |
3.6% |
| Abdominal Discomfort |
1.8% |
| Electrolyte Substitution Therapy |
1.8% |
| Osteoporosis |
1.8% |
| Sedative Therapy |
1.8% |
|
| Vomiting |
20.0% |
| Phlebitis |
13.3% |
| Tearfulness |
13.3% |
| Vaginal Polyp |
13.3% |
| Breast Cancer Female |
6.7% |
| Carbohydrate Antigen 125 Increased |
6.7% |
| Impaired Healing |
6.7% |
| Ovarian Cancer Metastatic |
6.7% |
| Somnolence |
6.7% |
| Vaginal Haemorrhage |
6.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.7% |
| Drug Use For Unknown Indication |
16.3% |
| Rheumatoid Arthritis |
10.7% |
| Pain |
8.5% |
| Hormone Replacement Therapy |
3.8% |
| Premedication |
3.7% |
| Hypertension |
2.8% |
| Depression |
2.7% |
| Menopause |
2.5% |
| Hypothyroidism |
2.3% |
| Osteoporosis |
1.8% |
| Blood Follicle Stimulating Hormone Decreased |
1.7% |
| Blood Luteinising Hormone Decreased |
1.7% |
| Gastric Disorder |
1.5% |
| Acth Decreased |
1.4% |
| Follicle-stimulating Hormone Deficiency |
1.4% |
| Hypogonadism |
1.4% |
| Ovarian Disorder |
1.4% |
| Primary Hypothyroidism |
1.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.3% |
|
| Weight Increased |
13.5% |
| Vomiting |
10.8% |
| Wheezing |
9.9% |
| Femur Fracture |
6.3% |
| Diarrhoea |
4.5% |
| Malaise |
4.5% |
| Ovarian Cyst |
4.5% |
| Pain |
4.5% |
| Swollen Tongue |
4.5% |
| Dysphonia |
3.6% |
| Epilepsy |
3.6% |
| Fatigue |
3.6% |
| Sleep Apnoea Syndrome |
3.6% |
| Stress |
3.6% |
| Varicella |
3.6% |
| Varicose Vein |
3.6% |
| White Blood Cell Count Increased |
3.6% |
| Blood Pressure Increased |
2.7% |
| Bronchial Carcinoma |
2.7% |
| Bronchospasm |
2.7% |
|
